Genprex, Inc. (GNPX)

USD 0.29

(5.34%)

Net Income Summary of Genprex, Inc.

  • Genprex, Inc.'s latest annual net income in 2023 was -30.86 Million USD , down -4.74% from previous year.
  • Genprex, Inc.'s latest quarterly net income in 2024 Q1 was -5.96 Million USD , down -0.67% from previous quarter.
  • Genprex, Inc. reported an annual net income of -29.46 Million USD in 2022, down -50.39% from previous year.
  • Genprex, Inc. reported an annual net income of -19.59 Million USD in 2021, down -9.3% from previous year.
  • Genprex, Inc. reported a quarterly net income of -6.49 Million USD for 2024 Q2, down -8.83% from previous quarter.
  • Genprex, Inc. reported a quarterly net income of -9.13 Million USD for 2023 Q1, down -42.6% from previous quarter.

Annual Net Income Chart of Genprex, Inc. (2023 - 2015)

Historical Annual Net Income of Genprex, Inc. (2023 - 2015)

Year Net Income Net Income Growth
2023 -30.86 Million USD -4.74%
2022 -29.46 Million USD -50.39%
2021 -19.59 Million USD -9.3%
2020 -17.92 Million USD -68.22%
2019 -10.65 Million USD 13.88%
2018 -12.37 Million USD -273.32%
2017 -3.31 Million USD 19.8%
2016 -4.13 Million USD -286.28%
2015 -1.06 Million USD 0.0%

Peer Net Income Comparison of Genprex, Inc.

Name Net Income Net Income Difference
Sangamo Therapeutics, Inc. -257.83 Million USD 88.031%
IDEAYA Biosciences, Inc. -112.96 Million USD 72.68%
Eton Pharmaceuticals, Inc. -936 Thousand USD -3197.058%
Autolus Therapeutics plc -208.38 Million USD 85.191%
Greenwich LifeSciences, Inc. -8.89 Million USD -247.066%
Enlivex Therapeutics Ltd. -29.06 Million USD -6.166%
Shattuck Labs, Inc. -87.29 Million USD 64.649%
LENZ Therapeutics, Inc. -124.65 Million USD 75.243%
CervoMed Inc. -2.17 Million USD -1320.915%
Rocket Pharmaceuticals, Inc. -245.59 Million USD 87.434%
Corbus Pharmaceuticals Holdings, Inc. -44.6 Million USD 30.811%
Aptose Biosciences Inc. -51.2 Million USD 39.734%
Precision BioSciences, Inc. -61.31 Million USD 49.672%
Dyadic International, Inc. -6.79 Million USD -354.133%
TScan Therapeutics, Inc. -89.21 Million USD 65.41%
Intensity Therapeutics, Inc. -10.53 Million USD -192.849%
Nektar Therapeutics -276.05 Million USD 88.821%
CytomX Therapeutics, Inc. -569 Thousand USD -5323.631%
VYNE Therapeutics Inc. -28.45 Million USD -8.465%
EyePoint Pharmaceuticals, Inc. -70.79 Million USD 56.409%
Leap Therapeutics, Inc. -81.41 Million USD 62.094%
Adaptive Biotechnologies Corporation -225.25 Million USD 86.299%
GRI Bio, Inc. -13.03 Million USD -136.714%
Xenetic Biosciences, Inc. -4.13 Million USD -646.399%
Tenaya Therapeutics, Inc. -124.08 Million USD 75.129%
NeuroSense Therapeutics Ltd. -10.1 Million USD -205.337%
Psyence Biomedical Ltd. -51.15 Million USD 39.677%
IGM Biosciences, Inc. -246.41 Million USD 87.476%
INmune Bio, Inc. -30 Million USD -2.841%
Opthea Limited -220.24 Million USD 85.988%
Milestone Pharmaceuticals Inc. -59.68 Million USD 48.294%
Omega Therapeutics, Inc. -97.42 Million USD 68.325%
Verastem, Inc. -87.36 Million USD 64.677%
Abeona Therapeutics Inc. -54.18 Million USD 43.049%
Pliant Therapeutics, Inc. -161.33 Million USD 80.872%
Tonix Pharmaceuticals Holding Corp. -116.65 Million USD 73.546%
Ligand Pharmaceuticals Incorporated 52.15 Million USD 159.172%
NextCure, Inc. -62.72 Million USD 50.799%
Inhibikase Therapeutics, Inc. -19.02 Million USD -62.177%
Organovo Holdings, Inc. -14.67 Million USD -110.35%
Lixte Biotechnology Holdings, Inc. -5.08 Million USD -506.65%
Arvinas, Inc. -367.3 Million USD 91.598%
Ovid Therapeutics Inc. -52.33 Million USD 41.037%
CASI Pharmaceuticals, Inc. -26.93 Million USD -14.561%
Rani Therapeutics Holdings, Inc. -33.97 Million USD 9.154%
Centessa Pharmaceuticals plc -151.08 Million USD 79.574%
Arcturus Therapeutics Holdings Inc. -29.72 Million USD -3.82%
Syros Pharmaceuticals, Inc. -164.57 Million USD 81.248%
Senti Biosciences, Inc. -92.91 Million USD 66.788%
BioRestorative Therapies, Inc. -10.41 Million USD -196.231%
Apollomics, Inc. -172.6 Million USD 82.12%
PureTech Health plc -65.69 Million USD 53.026%
Oncternal Therapeutics, Inc. -39.47 Million USD 21.831%
Barinthus Biotherapeutics plc -73.34 Million USD 57.925%
Kymera Therapeutics, Inc. -146.96 Million USD 79.001%
Synaptogenix, Inc. -6.03 Million USD -411.061%
ChromaDex Corporation -4.93 Million USD -524.959%
Beam Therapeutics Inc. -132.52 Million USD 76.714%
Monopar Therapeutics Inc. -8.4 Million USD -267.29%
Akebia Therapeutics, Inc. -51.92 Million USD 40.567%
Nurix Therapeutics, Inc. -143.94 Million USD 78.561%
Apellis Pharmaceuticals, Inc. -528.62 Million USD 94.162%
Dermata Therapeutics, Inc. -7.79 Million USD -295.916%
Gritstone bio, Inc. -138.49 Million USD 77.716%
Mesoblast Limited -87.95 Million USD 64.914%
Virpax Pharmaceuticals, Inc. -15.18 Million USD -103.17%
Xeris Biopharma Holdings, Inc. -62.25 Million USD 50.429%
Fate Therapeutics, Inc. -160.92 Million USD 80.823%
MediWound Ltd. -6.71 Million USD -359.507%
BioXcel Therapeutics, Inc. -179.05 Million USD 82.765%
Fortress Biotech, Inc. -60.63 Million USD 49.106%
Fractyl Health, Inc. Common Stock -77.09 Million USD 59.969%
Achilles Therapeutics plc -69.66 Million USD 55.702%
Seres Therapeutics, Inc. -113.72 Million USD 72.864%
Checkpoint Therapeutics, Inc. -51.84 Million USD 40.478%
Atossa Therapeutics, Inc. -30.09 Million USD -2.547%
Zai Lab Limited -334.62 Million USD 90.777%
Fresh Tracks Therapeutics, Inc. -5.69 Million USD -441.982%
Lyell Immunopharma, Inc. -234.63 Million USD 86.847%
Vanda Pharmaceuticals Inc. 2.5 Million USD 1329.99%
Tarsus Pharmaceuticals, Inc. -135.89 Million USD 77.291%
InMed Pharmaceuticals Inc. -7.67 Million USD -302.062%
FibroGen, Inc. -284.23 Million USD 89.143%
Celcuity Inc. -63.77 Million USD 51.614%
SeaStar Medical Holding Corporation -26.23 Million USD -17.644%
ContextLogic Inc. -317 Million USD 90.265%
GH Research PLC -35.58 Million USD 13.282%
HOOKIPA Pharma Inc. -81.58 Million USD 62.172%
Cyclacel Pharmaceuticals, Inc. -22.55 Million USD -36.823%
ImmuCell Corporation -5.77 Million USD -434.417%
Amylyx Pharmaceuticals, Inc. 49.27 Million USD 162.634%
Amarin Corporation plc -59.11 Million USD 47.793%
TG Therapeutics, Inc. 12.67 Million USD 343.533%
Aptevo Therapeutics Inc. -17.41 Million USD -77.247%
Jasper Therapeutics, Inc. -64.46 Million USD 52.128%
Foghorn Therapeutics Inc. -98.42 Million USD 68.646%
Y-mAbs Therapeutics, Inc. -21.42 Million USD -44.026%
Aptorum Group Limited -2.82 Million USD -992.542%
Ultragenyx Pharmaceutical Inc. -606.63 Million USD 94.913%
BioCryst Pharmaceuticals, Inc. -226.53 Million USD 86.377%
Chemomab Therapeutics Ltd. -24.22 Million USD -27.412%
Arrowhead Pharmaceuticals, Inc. -205.27 Million USD 84.966%
TransCode Therapeutics, Inc. -18.54 Million USD -66.399%
RAPT Therapeutics, Inc. -116.79 Million USD 73.578%
Ardelyx, Inc. -66.06 Million USD 53.289%
Ainos, Inc. -13.77 Million USD -124.105%
Lyra Therapeutics, Inc. -62.68 Million USD 50.765%
Prothena Corporation plc -147.02 Million USD 79.01%
HilleVax, Inc. -123.56 Million USD 75.025%
Adaptimmune Therapeutics plc -113.87 Million USD 72.899%
Celularity Inc. -196.29 Million USD 84.279%
Rallybio Corporation -74.56 Million USD 58.612%
Cue Biopharma, Inc. -50.73 Million USD 39.171%
Omeros Corporation -117.81 Million USD 73.806%
Humacyte, Inc. -110.77 Million USD 72.142%
Immunocore Holdings plc -55.28 Million USD 44.181%
Cocrystal Pharma, Inc. -17.98 Million USD -71.6%
Blueprint Medicines Corporation -506.98 Million USD 93.913%
IO Biotech, Inc. -86.08 Million USD 64.15%
MEI Pharma, Inc. 17.77 Million USD 273.588%
GT Biopharma, Inc. -7.59 Million USD -306.219%
Cabaletta Bio, Inc. -67.67 Million USD 54.399%
Summit Therapeutics Inc. -614.92 Million USD 94.981%
Alaunos Therapeutics, Inc. -35.14 Million USD 12.179%
Marinus Pharmaceuticals, Inc. -141.4 Million USD 78.176%
Scholar Rock Holding Corporation -165.78 Million USD 81.386%
Pulmatrix, Inc. -14.12 Million USD -118.543%
Elicio Therapeutics, Inc. -35.19 Million USD 12.316%
X4 Pharmaceuticals, Inc. -101.16 Million USD 69.496%
Vigil Neuroscience, Inc. -82.63 Million USD 62.656%
Acelyrin, Inc. -381.64 Million USD 91.914%
Intellia Therapeutics, Inc. -481.19 Million USD 93.587%
Cytokinetics, Incorporated -526.24 Million USD 94.136%
Vor Biopharma Inc. -117.86 Million USD 73.817%
Evogene Ltd. -23.87 Million USD -29.237%
Replimune Group, Inc. -215.79 Million USD 85.699%
Applied Therapeutics, Inc. -119.76 Million USD 74.232%
PDS Biotechnology Corporation -42.94 Million USD 28.135%
Hoth Therapeutics, Inc. -7.84 Million USD -293.358%
BridgeBio Pharma, Inc. -643.2 Million USD 95.202%
AEON Biopharma, Inc. -52.55 Million USD 41.281%
BioLineRx Ltd. -60.61 Million USD 49.087%
Galectin Therapeutics Inc. -41.06 Million USD 24.852%
Atai Life Sciences N.V. -40.22 Million USD 23.278%
Aerovate Therapeutics, Inc. -75.52 Million USD 59.137%
VistaGen Therapeutics, Inc. -29.36 Million USD -5.103%
Zentalis Pharmaceuticals, Inc. -292.19 Million USD 89.438%
Sagimet Biosciences Inc. -27.87 Million USD -10.706%
MediciNova, Inc. -8.57 Million USD -260.035%
Praxis Precision Medicines, Inc. -123.27 Million USD 74.967%
MiMedx Group, Inc. 67.43 Million USD 145.761%
Cardio Diagnostics Holdings, Inc. -8.37 Million USD -268.402%
Axsome Therapeutics, Inc. -239.23 Million USD 87.101%
PTC Therapeutics, Inc. -626.6 Million USD 95.075%
Mereo BioPharma Group plc -29.46 Million USD -4.732%
Syndax Pharmaceuticals, Inc. -209.36 Million USD 85.26%
NRx Pharmaceuticals, Inc. -30.15 Million USD -2.356%
Dyne Therapeutics, Inc. -235.93 Million USD 86.92%
BriaCell Therapeutics Corp. -4.79 Million USD -544.071%
Allakos Inc. -185.7 Million USD 83.382%
scPharmaceuticals Inc. -54.81 Million USD 43.696%
Fulcrum Therapeutics, Inc. -97.33 Million USD 68.295%
Corcept Therapeutics Incorporated 106.14 Million USD 129.075%
NLS Pharmaceutics AG -12.17 Million USD -153.536%
Precigen, Inc. -95.9 Million USD 67.822%
XOMA Corporation -40.83 Million USD 24.419%
Kezar Life Sciences, Inc. -101.87 Million USD 69.706%
Incyte Corporation 597.59 Million USD 105.164%
Alzamend Neuro, Inc. -9.94 Million USD -210.226%
Cara Therapeutics, Inc. -118.51 Million USD 73.96%
Aligos Therapeutics, Inc. -87.67 Million USD 64.803%
Seer, Inc. -86.27 Million USD 64.231%
Reviva Pharmaceuticals Holdings, Inc. -24.33 Million USD -26.793%
CRISPR Therapeutics AG -153.61 Million USD 79.91%
Akero Therapeutics, Inc. -151.75 Million USD 79.665%
Eliem Therapeutics, Inc. -35.11 Million USD 12.126%
EyeGate Pharmaceuticals, Inc. -8.09 Million USD -281.373%
Akari Therapeutics, Plc -10 Million USD -208.358%
Novavax, Inc. -545.06 Million USD 94.338%
Lexaria Bioscience Corp. -6.66 Million USD -363.03%
UroGen Pharma Ltd. -102.24 Million USD 69.817%
Sutro Biopharma, Inc. -106.79 Million USD 71.103%
Entera Bio Ltd. -8.88 Million USD -247.176%
Lisata Therapeutics, Inc. -20.84 Million USD -48.083%
Stoke Therapeutics, Inc. -104.69 Million USD 70.525%
Chimerix, Inc. -82.09 Million USD 62.409%
Reneo Pharmaceuticals, Inc. -77.38 Million USD 60.122%
Phathom Pharmaceuticals, Inc. -201.59 Million USD 84.692%
Outlook Therapeutics, Inc. -58.98 Million USD 47.679%
Jazz Pharmaceuticals plc 414.83 Million USD 107.439%
AnaptysBio, Inc. -163.61 Million USD 81.139%
Aprea Therapeutics, Inc. -14.28 Million USD -116.007%
Portage Biotech Inc. -75.33 Million USD 59.038%
Olema Pharmaceuticals, Inc. -96.65 Million USD 68.072%
PMV Pharmaceuticals, Inc. -68.96 Million USD 55.249%
OKYO Pharma Limited -16.82 Thousand USD -183315.259%
Qualigen Therapeutics, Inc. -13.41 Million USD -130.007%
Cadrenal Therapeutics, Inc. Common Stock -8.35 Million USD -269.273%
Processa Pharmaceuticals, Inc. -11.12 Million USD -177.484%
AbCellera Biologics Inc. -146.39 Million USD 78.92%
Neumora Therapeutics, Inc. Common Stock -235.92 Million USD 86.919%
NLS Pharmaceutics AG -12.17 Million USD -153.536%
Virios Therapeutics, Inc. -5.29 Million USD -482.711%
Daré Bioscience, Inc. -30.16 Million USD -2.318%
Titan Pharmaceuticals, Inc. -5.56 Million USD -454.147%
Bicycle Therapeutics plc -180.66 Million USD 82.918%
Revolution Medicines, Inc. Warrant -436.36 Million USD 92.928%
Protagonist Therapeutics, Inc. -78.95 Million USD 60.914%
Erasca, Inc. -125.04 Million USD 75.32%
bluebird bio, Inc. -211.91 Million USD 85.437%
Pieris Pharmaceuticals, Inc. -24.54 Million USD -25.74%
BioMarin Pharmaceutical Inc. 167.64 Million USD 118.408%
DBV Technologies S.A. -72.72 Million USD 57.566%
Fortress Biotech, Inc. -60.63 Million USD 49.106%
Avidity Biosciences, Inc. -212.22 Million USD 85.458%
CorMedix Inc. -46.33 Million USD 33.403%
Travere Therapeutics, Inc. -111.39 Million USD 72.297%
Sensei Biotherapeutics, Inc. -34.1 Million USD 9.503%
Orchestra BioMed Holdings, Inc. -49.12 Million USD 37.173%
Spruce Biosciences, Inc. -47.91 Million USD 35.599%
Celldex Therapeutics, Inc. -141.42 Million USD 78.18%
Cartesian Therapeutics, Inc. -219.71 Million USD 85.954%
Cogent Biosciences, Inc. -192.41 Million USD 83.961%
Onconetix, Inc. -37.4 Million USD 17.507%
Ocuphire Pharma, Inc. -9.98 Million USD -209.037%
Prime Medicine, Inc. -198.13 Million USD 84.424%
Adagene Inc. -18.94 Million USD -62.883%
Inhibrx Biosciences, Inc. -241.36 Million USD 87.214%
GlycoMimetics, Inc. -36.89 Million USD 16.366%
Maravai LifeSciences Holdings, Inc. -119.02 Million USD 74.073%
Verve Therapeutics, Inc. -200.06 Million USD 84.575%
Voyager Therapeutics, Inc. 132.33 Million USD 123.321%
SciSparc Ltd. -5.12 Million USD -502.508%
Revelation Biosciences, Inc. -120.25 Thousand USD -25562.731%
Minerva Neurosciences, Inc. -30 Million USD -2.85%
Astria Therapeutics, Inc. -72.89 Million USD 57.662%
Spero Therapeutics, Inc. 22.8 Million USD 235.317%
Tevogen Bio Holdings Inc. -67.32 Thousand USD -45738.041%
Arcutis Biotherapeutics, Inc. -262.14 Million USD 88.227%
Marker Therapeutics, Inc. -14.04 Million USD -119.712%
Alnylam Pharmaceuticals, Inc. -440.24 Million USD 92.99%
Artelo Biosciences, Inc. -9.87 Million USD -212.543%
2seventy bio, Inc. -217.57 Million USD 85.816%
ADMA Biologics, Inc. -28.23 Million USD -9.283%
Clene Inc. -49.5 Million USD 37.661%
Capricor Therapeutics, Inc. -22.28 Million USD -38.465%
Boundless Bio, Inc. Common Stock -49.43 Million USD 37.572%
Recursion Pharmaceuticals, Inc. -328.06 Million USD 90.593%
Citius Pharmaceuticals, Inc. -32.54 Million USD 5.17%
Contineum Therapeutics, Inc. Class A Common Stock 22.72 Million USD 235.829%
Absci Corporation -110.56 Million USD 72.089%
Regeneron Pharmaceuticals, Inc. 3.95 Billion USD 100.781%
Surrozen, Inc. -43.04 Million USD 28.302%
Caribou Biosciences, Inc. -102.07 Million USD 69.765%
Janux Therapeutics, Inc. -58.29 Million USD 47.06%
Cingulate Inc. -23.53 Million USD -31.126%
Galmed Pharmaceuticals Ltd. -6.91 Million USD -346.477%
Tenax Therapeutics, Inc. -7.71 Million USD -300.23%
Jaguar Health, Inc. -41.3 Million USD 25.277%
Terns Pharmaceuticals, Inc. -90.21 Million USD 65.79%
ACADIA Pharmaceuticals Inc. -61.28 Million USD 49.645%
Kronos Bio, Inc. -112.67 Million USD 72.611%
Innoviva, Inc. 179.72 Million USD 117.171%
Bolt Biotherapeutics, Inc. -69.19 Million USD 55.402%
Entrada Therapeutics, Inc. -6.68 Million USD -361.637%
ZyVersa Therapeutics, Inc. -98.29 Million USD 68.605%
Soligenix, Inc. -6.14 Million USD -402.554%
AlloVir, Inc. -190.41 Million USD 83.793%
Century Therapeutics, Inc. -136.67 Million USD 77.42%
ORIC Pharmaceuticals, Inc. -100.69 Million USD 69.353%
Kura Oncology, Inc. -152.63 Million USD 79.781%
Ocean Biomedical, Inc. 565.47 Thousand USD 5557.489%
Mineralys Therapeutics, Inc. -71.89 Million USD 57.077%
Eterna Therapeutics Inc. -21.66 Million USD -42.424%
SELLAS Life Sciences Group, Inc. -37.34 Million USD 17.353%
Heron Therapeutics, Inc. -110.55 Million USD 72.087%
SAB Biotherapeutics, Inc. -42.19 Million USD 26.86%
Pasithea Therapeutics Corp. -15.96 Million USD -93.341%
Entero Therapeutics, Inc. -15.79 Million USD -95.381%
HCW Biologics Inc. -24.99 Million USD -23.47%
C4 Therapeutics, Inc. -132.49 Million USD 76.708%
Atara Biotherapeutics, Inc. -276.12 Million USD 88.824%
Coherus BioSciences, Inc. -237.89 Million USD 87.028%
Lantern Pharma Inc. -15.96 Million USD -93.343%
Histogen Inc. -10.62 Million USD -190.561%
Surrozen, Inc. -43.04 Million USD 28.302%
Eledon Pharmaceuticals, Inc. -40.32 Million USD 23.473%
Kodiak Sciences Inc. -260.49 Million USD 88.153%
MoonLake Immunotherapeutics -36 Million USD 14.294%
Hepion Pharmaceuticals, Inc. -48.92 Million USD 36.924%
Adverum Biotechnologies, Inc. -117.16 Million USD 73.661%
Avalo Therapeutics, Inc. -31.54 Million USD 2.167%
Moderna, Inc. -4.71 Billion USD 99.345%
Ionis Pharmaceuticals, Inc. -366.28 Million USD 91.575%
Turnstone Biologics Corp. -55.2 Million USD 44.093%
Immix Biopharma, Inc. -15.42 Million USD -100.054%
Tiziana Life Sciences Ltd -16.2 Million USD -90.403%
Aurinia Pharmaceuticals Inc. -78.02 Million USD 60.445%
Exelixis, Inc. 207.76 Million USD 114.854%
Monte Rosa Therapeutics, Inc. -135.35 Million USD 77.2%
Wave Life Sciences Ltd. -57.51 Million USD 46.342%
Conduit Pharmaceuticals Inc. -535 Thousand USD -5668.31%
Alkermes plc 355.75 Million USD 108.675%
Jasper Therapeutics, Inc. -64.46 Million USD 52.128%
Arcellx, Inc. -70.69 Million USD 56.344%
ESSA Pharma Inc. -26.58 Million USD -16.094%
TNF Pharmaceuticals, Inc. -3.99 Million USD -671.521%
Avid Bioservices, Inc. -140.75 Million USD 78.075%
Insmed Incorporated -749.56 Million USD 95.883%
Cardiff Oncology, Inc. -41.44 Million USD 25.532%
Enanta Pharmaceuticals, Inc. -133.81 Million USD 76.938%
Moolec Science SA -51.78 Million USD 40.411%
RenovoRx, Inc. -10.23 Million USD -201.607%
Acumen Pharmaceuticals, Inc. -52.37 Million USD 41.073%
Geron Corporation -184.12 Million USD 83.24%
LAVA Therapeutics N.V. -41.97 Million USD 26.477%
Verrica Pharmaceuticals Inc. -66.99 Million USD 53.936%
Royalty Pharma plc 1.13 Billion USD 102.719%
OmniAb, Inc. -50.61 Million USD 39.034%
Alector, Inc. -130.39 Million USD 76.332%
Atea Pharmaceuticals, Inc. -135.95 Million USD 77.301%
Mersana Therapeutics, Inc. -171.67 Million USD 82.023%
Humacyte, Inc. -110.77 Million USD 72.142%
Structure Therapeutics Inc. -89.62 Million USD 65.565%
Revance Therapeutics, Inc. -323.98 Million USD 90.475%
89bio, Inc. -142.18 Million USD 78.296%
Avenue Therapeutics, Inc. -10.37 Million USD -197.393%
Aura Biosciences, Inc. -76.4 Million USD 59.611%
Immunic, Inc. -93.61 Million USD 67.034%
Veracyte, Inc. -74.4 Million USD 58.523%
Genelux Corporation -28.29 Million USD -9.059%
Trevi Therapeutics, Inc. -29.06 Million USD -6.177%
Adial Pharmaceuticals, Inc. -7 Million USD -340.745%
Sonnet BioTherapeutics Holdings, Inc. -18.83 Million USD -63.866%
Immunovant, Inc. -259.33 Million USD 88.1%
Vericel Corporation -3.18 Million USD -869.845%
Fortrea Holdings Inc. -3.4 Million USD -807.661%
KalVista Pharmaceuticals, Inc. -126.64 Million USD 75.632%
XBiotech Inc. -24.55 Million USD -25.669%
Agenus Inc. -245.76 Million USD 87.443%
Acasti Pharma Inc. -12.85 Million USD -140.103%
Kiora Pharmaceuticals, Inc. -12.51 Million USD -146.61%
MiNK Therapeutics, Inc. -22.45 Million USD -37.415%
Pasithea Therapeutics Corp. -15.96 Million USD -93.341%
Theravance Biopharma, Inc. -55.19 Million USD 44.086%
Metagenomi, Inc. Common Stock -68.25 Million USD 54.787%
NeuroBo Pharmaceuticals, Inc. -12.47 Million USD -147.478%
Gain Therapeutics, Inc. -22.26 Million USD -38.59%
Tempest Therapeutics, Inc. -29.49 Million USD -4.644%
Sol-Gel Technologies Ltd. -27.23 Million USD -13.299%
Rhythm Pharmaceuticals, Inc. -184.67 Million USD 83.29%
United Therapeutics Corporation 984.8 Million USD 103.134%
Creative Medical Technology Holdings, Inc. -5.28 Million USD -483.752%
BriaCell Therapeutics Corp. -4.79 Million USD -544.071%
Lixte Biotechnology Holdings, Inc. -5.08 Million USD -506.65%
Silo Pharma, Inc. -3.7 Million USD -733.913%
Telomir Pharmaceuticals, Inc. Common Stock -13.07 Million USD -136.083%
Pharming Group N.V. -10.54 Million USD -192.572%
XOMA Corporation -40.83 Million USD 24.419%
Reviva Pharmaceuticals Holdings, Inc. -24.33 Million USD -26.793%
Bionomics Limited -15.49 Billion USD 99.801%
Alpha Tau Medical Ltd. -29.15 Million USD -5.842%
Pyxis Oncology, Inc. -73.79 Million USD 58.178%
uniQure N.V. -308.47 Million USD 89.996%
Xilio Therapeutics, Inc. -76.4 Million USD 59.609%
Cassava Sciences, Inc. -97.21 Million USD 68.256%
60 Degrees Pharmaceuticals, Inc. -3.76 Million USD -719.514%
Windtree Therapeutics, Inc. -20.29 Million USD -52.089%
Poseida Therapeutics, Inc. -123.43 Million USD 74.998%
Pluri Inc. -20.88 Million USD -47.743%
Anebulo Pharmaceuticals, Inc. -8.2 Million USD -276.269%
MeiraGTx Holdings plc -84.02 Million USD 63.273%
Cidara Therapeutics, Inc. -22.93 Million USD -34.58%
ProMIS Neurosciences, Inc. -17.5 Million USD -76.284%
CalciMedica, Inc. -34.35 Million USD 10.177%
Sana Biotechnology, Inc. -283.25 Million USD 89.105%
Amicus Therapeutics, Inc. -151.58 Million USD 79.641%
Salarius Pharmaceuticals, Inc. -12.54 Thousand USD -245943.401%
Alpha Tau Medical Ltd. -29.15 Million USD -5.842%
Adlai Nortye Ltd. American Depositary Shares -104.87 Million USD 70.573%
Nutriband Inc. -5.48 Million USD -462.602%
Protara Therapeutics, Inc. -40.42 Million USD 23.651%
Compugen Ltd. -18.75 Million USD -64.554%
Roivant Sciences Ltd. 4.34 Billion USD 100.71%
ProKidney Corp. -35.46 Million USD 12.991%
Protagenic Therapeutics, Inc. -5 Million USD -517.148%
Elevai Labs, Inc. Common Stock -4.3 Million USD -617.432%
Tango Therapeutics, Inc. -101.74 Million USD 69.669%
Renovaro Biosciences Inc. -80.65 Million USD 61.735%
Zevra Therapeutics, Inc. -46.04 Million USD 32.983%
Benitec Biopharma Inc. -21.75 Million USD -41.881%
GeoVax Labs, Inc. -25.96 Million USD -18.846%
Biomea Fusion, Inc. -117.25 Million USD 73.681%
Cullinan Oncology, Inc. -153.16 Million USD 79.851%
4D Molecular Therapeutics, Inc. -100.83 Million USD 69.396%
Kiniksa Pharmaceuticals, Ltd. 14.08 Million USD 319.117%
Nuvectis Pharma, Inc. -22.26 Million USD -38.636%
Spyre Therapeutics, Inc. -338.79 Million USD 90.891%
Ventyx Biosciences, Inc. -192.96 Million USD 84.007%
Imunon, Inc. -19.51 Million USD -58.137%
BioAtla, Inc. -123.46 Million USD 75.004%
Allogene Therapeutics, Inc. -327.26 Million USD 90.57%
Larimar Therapeutics, Inc. -36.94 Million USD 16.478%
Zura Bio Limited -60.36 Million USD 48.873%
aTyr Pharma, Inc. -50.38 Million USD 38.756%
Madrigal Pharmaceuticals, Inc. -373.63 Million USD 91.74%
Viridian Therapeutics, Inc. -237.73 Million USD 87.019%
Galecto, Inc. -38.34 Million USD 19.527%
Tevogen Bio Holdings Inc. -67.32 Thousand USD -45738.041%
Halozyme Therapeutics, Inc. 281.59 Million USD 110.959%
Lexicon Pharmaceuticals, Inc. -177.11 Million USD 82.576%
PolyPid Ltd. -23.86 Million USD -29.313%
Aileron Therapeutics, Inc. -15.73 Million USD -96.164%
Forte Biosciences, Inc. -31.47 Million USD 1.956%
Xencor, Inc. -126.08 Million USD 75.524%
Coeptis Therapeutics Holdings, Inc. -21.26 Million USD -45.113%
Lexaria Bioscience Corp. -6.66 Million USD -363.03%
Instil Bio, Inc. -156.08 Million USD 80.229%
Cardio Diagnostics Holdings, Inc. -8.37 Million USD -268.402%
OncoCyte Corporation -27.78 Million USD -11.085%
Elevation Oncology, Inc. -45.7 Million USD 32.478%
Purple Biotech Ltd. -19.88 Million USD -55.234%
CollPlant Biotechnologies Ltd. -7.01 Million USD -339.67%
MacroGenics, Inc. -9.05 Million USD -240.698%
Verona Pharma plc -54.36 Million USD 43.239%
Tharimmune, Inc. -9.31 Million USD -231.153%
Apogee Therapeutics, Inc. -83.98 Million USD 63.255%
enGene Holdings Inc. Warrants -99.91 Million USD 69.114%
Aditxt, Inc. -32.38 Million USD 4.695%
XTL Biopharmaceuticals Ltd. -1.78 Million USD -1631.788%
Savara Inc. -54.69 Million USD 43.58%
Curis, Inc. -47.41 Million USD 34.911%
Carmell Therapeutics Corporation -15.44 Million USD -99.808%
Achieve Life Sciences, Inc. -29.81 Million USD -3.506%
BeiGene, Ltd. -881.7 Million USD 96.5%
Protagenic Therapeutics, Inc. -5 Million USD -517.148%
Vincerx Pharma, Inc. -40.15 Million USD 23.15%
Plus Therapeutics, Inc. -13.31 Million USD -131.755%
Acrivon Therapeutics, Inc. Common Stock -60.38 Million USD 48.896%
Rigel Pharmaceuticals, Inc. -25.09 Million USD -22.994%
Adicet Bio, Inc. -142.65 Million USD 78.368%
Estrella Immunopharma, Inc. -7.31 Million USD -322.068%
Quantum-Si incorporated -95.96 Million USD 67.84%
Acurx Pharmaceuticals, Inc. -14.57 Million USD -111.695%
Generation Bio Co. -126.61 Million USD 75.626%
Black Diamond Therapeutics, Inc. -82.44 Million USD 62.567%
Invivyd, Inc. -198.64 Million USD 84.464%
Relay Therapeutics, Inc. -341.97 Million USD 90.976%
Quoin Pharmaceuticals, Ltd. -8.68 Million USD -255.266%
Moolec Science SA -51.78 Million USD 40.411%
Clearside Biomedical, Inc. -32.48 Million USD 5.001%
Longboard Pharmaceuticals, Inc. -54.42 Million USD 43.294%
Relmada Therapeutics, Inc. -98.79 Million USD 68.762%
ALX Oncology Holdings Inc. -160.8 Million USD 80.809%
Vir Biotechnology, Inc. -615.06 Million USD 94.983%
Evaxion Biotech A/S -22.12 Million USD -39.482%
Ocular Therapeutix, Inc. -80.73 Million USD 61.776%
Tyra Biosciences, Inc. -69.13 Million USD 55.361%
Unity Biotechnology, Inc. -39.86 Million USD 22.578%
Connect Biopharma Holdings Limited -59.5 Million USD 48.136%
Clearmind Medicine Inc. -11.95 Million USD -158.138%
Aadi Bioscience, Inc. -65.76 Million USD 53.075%
Catalyst Pharmaceuticals, Inc. 71.41 Million USD 143.216%
CERo Therapeutics Holdings, Inc. -2536.23 USD -1216684.795%
Viking Therapeutics, Inc. -85.89 Million USD 64.072%
Keros Therapeutics, Inc. -152.99 Million USD 79.829%
Crinetics Pharmaceuticals, Inc. -214.52 Million USD 85.615%
ImmunityBio, Inc. -583.19 Million USD 94.708%
Korro Bio, Inc. -81.17 Million USD 61.981%
Kineta, Inc. -14.09 Million USD -118.884%
BioVie Inc. -32.12 Million USD 3.923%
Codexis, Inc. -76.24 Million USD 59.522%
Celularity Inc. -196.29 Million USD 84.279%
Virax Biolabs Group Limited -6.73 Million USD -358.31%
Cibus, Inc. -267.62 Million USD 88.469%
Annexon, Inc. -134.23 Million USD 77.01%
Assembly Biosciences, Inc. -61.22 Million USD 49.597%
Eyenovia, Inc. -27.26 Million USD -13.203%
Puma Biotechnology, Inc. 21.59 Million USD 242.932%
NeurAxis, Inc. -14.62 Million USD -110.987%
Regulus Therapeutics Inc. -30.03 Million USD -2.741%
Compass Therapeutics, Inc. -42.49 Million USD 27.377%
TFF Pharmaceuticals, Inc. -21.24 Million USD -45.272%
Notable Labs, Ltd. -11.26 Million USD -173.974%
IN8bio, Inc. -30 Million USD -2.844%
DiaMedica Therapeutics Inc. -19.38 Million USD -59.23%
Vera Therapeutics, Inc. -95.99 Million USD 67.85%
Lumos Pharma, Inc. -34.03 Million USD 9.325%
Liquidia Corporation -78.5 Million USD 60.688%
Mustang Bio, Inc. -51.6 Million USD 40.195%
Quantum-Si incorporated -95.96 Million USD 67.84%
Arbutus Biopharma Corporation -72.84 Million USD 57.638%
enGene Holdings Inc. Common Stock -99.91 Million USD 69.114%
ARS Pharmaceuticals, Inc. -54.36 Million USD 43.235%
180 Life Sciences Corp. -19.93 Million USD -54.805%
Vaxcyte, Inc. -402.26 Million USD 92.328%
Xenon Pharmaceuticals Inc. -182.39 Million USD 83.08%
Estrella Immunopharma, Inc. -7.31 Million USD -322.068%
NKGen Biotech, Inc. Warrants -82.95 Million USD 62.798%
Opiant Pharmaceuticals, Inc. 3 Million USD 1125.677%
CERo Therapeutics Holdings, Inc. -2536.23 USD -1216684.795%
Soleno Therapeutics, Inc. -38.98 Million USD 20.846%
PepGen Inc. -78.62 Million USD 60.75%
Moleculin Biotech, Inc. -29.76 Million USD -3.666%
Solid Biosciences Inc. -96.01 Million USD 67.859%
Palisade Bio, Inc. -12.3 Million USD -150.898%
Nutriband Inc. -5.48 Million USD -462.602%
Conduit Pharmaceuticals Inc. -535 Thousand USD -5668.31%
Immuneering Corporation -53.47 Million USD 42.286%
Belite Bio, Inc -31.63 Million USD 2.439%
CG Oncology, Inc. Common stock -48.6 Million USD 36.51%
GeoVax Labs, Inc. -25.96 Million USD -18.846%
Tourmaline Bio, Inc. -42.12 Million USD 26.739%
Altimmune, Inc. -88.44 Million USD 65.109%
Peak Bio, Inc. -1259.26 USD -2450582.226%
SeaStar Medical Holding Corporation -26.23 Million USD -17.644%
FibroBiologics, Inc. Common Stock -16.48 Million USD -87.203%
Neurogene Inc. -36.31 Million USD 15.025%
Mirum Pharmaceuticals, Inc. -163.41 Million USD 81.115%
Kintara Therapeutics, Inc. -8.5 Million USD -263.022%
CARGO Therapeutics, Inc. Common Stock -98.14 Million USD 68.557%
Sesen Bio, Inc. -19.88 Million USD -55.202%
argenx SE -295.05 Million USD 89.541%
NKGen Biotech, Inc. Common Stock -82.95 Million USD 62.798%
Dianthus Therapeutics, Inc. -43.55 Million USD 29.146%
Immunome, Inc. -106.8 Million USD 71.106%
Enveric Biosciences, Inc. -17.29 Thousand USD -178369.482%
Design Therapeutics, Inc. -66.86 Million USD 53.845%
Seelos Therapeutics, Inc. -37.88 Million USD 18.535%
Enliven Therapeutics, Inc. -71.58 Million USD 56.889%
Iovance Biotherapeutics, Inc. -444.03 Million USD 93.05%
Taysha Gene Therapies, Inc. -111.56 Million USD 72.339%
Inovio Pharmaceuticals, Inc. -135.11 Million USD 77.16%
Athira Pharma, Inc. -117.67 Million USD 73.774%
XOMA Corporation -40.83 Million USD 24.419%
Merus N.V. -154.93 Million USD 80.082%
Quince Therapeutics, Inc. -31.38 Million USD 1.671%
Rezolute, Inc. -68.45 Million USD 54.921%
Clene Inc. -49.5 Million USD 37.661%
Indaptus Therapeutics, Inc. -15.42 Million USD -100.088%
BeyondSpring Inc. -21.02 Million USD -46.773%
Synlogic, Inc. -57.28 Million USD 46.125%
Allarity Therapeutics, Inc. -11.9 Million USD -159.31%
Phio Pharmaceuticals Corp. -10.82 Million USD -185.059%
Peak Bio, Inc. -1259.26 USD -2450582.226%
Werewolf Therapeutics, Inc. -37.36 Million USD 17.415%
Krystal Biotech, Inc. 10.93 Million USD 382.295%
Karyopharm Therapeutics Inc. -143.09 Million USD 78.434%
SpringWorks Therapeutics, Inc. -325.1 Million USD 90.508%
Lipella Pharmaceuticals Inc. -4.61 Million USD -568.125%
MannKind Corporation -11.93 Million USD -158.506%
Ikena Oncology, Inc. -68.16 Million USD 54.727%
Cyclerion Therapeutics, Inc. -21.01 Million USD -46.85%
Gyre Therapeutics, Inc. -92.93 Million USD 66.793%
Gossamer Bio, Inc. -179.81 Million USD 82.838%
CohBar, Inc. -11.96 Million USD -157.985%
Cognition Therapeutics, Inc. -25.78 Million USD -19.67%
NRx Pharmaceuticals, Inc. -30.15 Million USD -2.356%
Legend Biotech Corporation -518.25 Million USD 94.045%
Mural Oncology plc -207.44 Million USD 85.124%
Disc Medicine, Inc. -76.42 Million USD 59.622%
Champions Oncology, Inc. -7.27 Million USD -324.14%
REGENXBIO Inc. -263.49 Million USD 88.288%
Ensysce Biosciences, Inc. -10.61 Million USD -190.778%
Anavex Life Sciences Corp. -47.5 Million USD 35.037%
Cellectar Biosciences, Inc. -37.98 Million USD 18.753%
Edgewise Therapeutics, Inc. -100.16 Million USD 69.19%
Vaxart, Inc. -82.46 Million USD 62.578%
PharmaCyte Biotech, Inc. 333.76 Thousand USD 9346.22%
Aldeyra Therapeutics, Inc. -37.54 Million USD 17.799%
Cellectis S.A. -101.05 Million USD 69.463%
Longeveron Inc. -21.41 Million USD -44.12%
Repare Therapeutics Inc. -93.79 Million USD 67.098%
Sarepta Therapeutics, Inc. -535.97 Million USD 94.242%
Inozyme Pharma, Inc. -71.16 Million USD 56.638%
Revolution Medicines, Inc. -436.36 Million USD 92.928%
Nymox Pharmaceutical Corporation -6.57 Million USD -369.646%
Third Harmonic Bio, Inc. -30.82 Million USD -0.118%
ArriVent BioPharma, Inc. Common Stock -69.33 Million USD 55.49%
AN2 Therapeutics, Inc. -64.73 Million USD 52.326%
Anixa Biosciences, Inc. -9.81 Million USD -214.55%
Vertex Pharmaceuticals Incorporated 3.61 Billion USD 100.853%
Denali Therapeutics Inc. -145.22 Million USD 78.75%
Revelation Biosciences, Inc. -120.25 Thousand USD -25562.731%
Veru Inc. -93.15 Million USD 66.871%
Corvus Pharmaceuticals, Inc. -27.02 Million USD -14.175%
Cingulate Inc. -23.53 Million USD -31.126%
Passage Bio, Inc. -102.06 Million USD 69.763%
Context Therapeutics Inc. -23.96 Million USD -28.777%
Exicure, Inc. -16.91 Million USD -82.455%
Day One Biopharmaceuticals, Inc. -188.91 Million USD 83.665%
Oramed Pharmaceuticals Inc. -37.76 Million USD 18.281%
Scinai Immunotherapeutics Ltd. -6.5 Million USD -374.242%
Nuvalent, Inc. -126.21 Million USD 75.55%
ABVC BioPharma, Inc. -10.51 Million USD -193.472%
Carisma Therapeutics, Inc. -86.87 Million USD 64.479%
Unicycive Therapeutics, Inc. -30.54 Million USD -1.036%
OmniAb, Inc. -50.61 Million USD 39.034%
Anew Medical, Inc. 1.34 Million USD 2392.541%
Fennec Pharmaceuticals Inc. -16.04 Million USD -92.337%
Lipocine Inc. -16.35 Million USD -88.725%
Lexeo Therapeutics, Inc. Common Stock -66.39 Million USD 53.519%
Nautilus Biotechnology, Inc. -63.67 Million USD 51.534%
SAB Biotherapeutics, Inc. -42.19 Million USD 26.86%
G1 Therapeutics, Inc. -47.96 Million USD 35.663%
Bellerophon Therapeutics, Inc. -19.83 Million USD -55.617%
Sage Therapeutics, Inc. -541.48 Million USD 94.301%
Ocugen, Inc. -63.07 Million USD 51.076%
Mind Medicine (MindMed) Inc. -95.73 Million USD 67.764%
Q32 Bio Inc. -112.96 Million USD 72.68%
Brainstorm Cell Therapeutics Inc. -17.19 Million USD -79.505%
Alumis Inc. Common Stock -154.99 Million USD 80.089%
Equillium, Inc. -13.33 Million USD -131.425%
Kyverna Therapeutics, Inc. -60.36 Million USD 48.878%
Coya Therapeutics, Inc. -7.98 Million USD -286.343%
CNS Pharmaceuticals, Inc. -18.85 Million USD -63.705%
Dominari Holdings Inc. -22.88 Million USD -34.868%
Edesa Biotech, Inc. -8.37 Million USD -268.509%
vTv Therapeutics Inc. -20.25 Million USD -52.397%
Bio-Techne Corporation 168.1 Million USD 118.358%
Agios Pharmaceuticals, Inc. -352.08 Million USD 91.235%
Harmony Biosciences Holdings, Inc. 128.85 Million USD 123.95%
Prelude Therapeutics Incorporated -121.83 Million USD 74.67%
Candel Therapeutics, Inc. -37.93 Million USD 18.658%
iTeos Therapeutics, Inc. -112.64 Million USD 72.603%
Nkarta, Inc. -117.5 Million USD 73.736%
BioCardia, Inc. -11.57 Million USD -166.705%
Iterum Therapeutics plc -38.37 Million USD 19.573%